Insomnia drug improves work performance: Sanofi
|
Data show improvements in work performance in patients with chronic insomnia who are treated with the sleep aid Ambien (zolpidem tartrate), French pharmaceutical group Sanofi-Aventis said Wednesday
“Patients with chronic insomnia can have a higher frequency of work-related problems including absenteeism, an increased rate of accidents, difficulty performing duties and less job satisfaction,” Sanofi said in a statement.
These results, which are part of a larger study to evaluate the efficiency and safety of Ambien, were recently presented at the 20th annual U.S. psychiatric and mental health congress in Florida, Sanofi said in a statement.
Print Version
Tell-a-Friend comments powered by Disqus